IB
immatics biotechnologies GmbH
🇩🇪XFRA.4A3GermanyHealthcare
€7.38EURdown -0.15 (-1.99%)OpenEnd of day6:02 PM
Price€7.38-0.15 (-1.99%)
Profile
- Healthcare
- Biotechnology
- Germany
Identity
- Exchange
- Frankfurt Stock Exchange . XFRA
- Type
- Stock
- ISIN
- NL0015285941
- CUSIP
- Not reported
Company
- Employees
- 704
- Headquarters
- Tübingen, Germany
- Website
- https://www.immatics.com
- CEO
- Dr. Harpreet Singh Ph.D.
Market
- Shares outstanding
- 152.2M
- Market cap
- €1.12B
Key dates
- Next earnings
- Nov 17, 2026
Highlights
No high and low reported for today's session.
- Market cap
- €1.12B
- EPS LTM
- -€1.36calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- -5.44calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- €41.7M-67.95%down year on year
- Net income
- -€206.55M-192.38%down year on year
- Gross margin
- 100%0%unchanged year on year
- Free cash flow
- -€209.62M-19.99%down year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.